Now in its second edition, Hematology Board Review has been thoroughly revised and updated to contain the latest information that fellows and clinicians need to successfully prepare for the Hematology Certification Exam administered by the American Board of Internal Medicine (ABIM). The new edition now contains even more high yield board study content and review questions.
For the hematology-oncology fellow, hematologist, medical oncologist, or internist looking to review a given disease or blueprint category prior to their examination, this extremely practical study guide provides the pertinent points of emphasis that are often highlighted on the exam. Chapters on blood disorders and disease sites cover epidemiology, etiology and risk factors, staging, signs and symptoms, diagnostic criteria, indications for treatment, prognostic factors, treatment recommendations, and special considerations. Clinical pearls on other major subspecialty areas found on the exam include hematologic emergencies and supportive care, transfusion medicine, stem cell biology and hematopoiesis, cellular therapy, management of hematologic disease, complications after cellular therapy, and biostatistics. With 240 practice questions, detailed rationales, and a convenient print + digital package, Hematology Board Review gives you the tools to study your way and the confidence to pass the first time!
Rami N. Khoriaty, MD is an Associate Professor in the Department of Internal Medicine, Division of Hematology/Oncology at the University of Michigan Medical School in Ann Arbor, Michigan.
Morgan Jones, MD, PhD is a Clinical Professor in the Department of Internal Medicine, Division of Hematology/Oncology, at the University of Michigan Medical School in Ann Arbor, Michigan.
Francis P. Worden, MD is a Professor of Medicine and Director of the Hematology/Oncology Fellowship Program at the University of Michigan Medical School in Ann Arbor, Michigan.
List of Contributors
Preface
Chapter 1. Stem Cell Biology and Hematopoeisis
Chapter 2. Red Blood Cell Production Disorders
Chapter 3. Red Blood Cell Destruction Disorders
Chapter 4. Hemoglobinopathies
Chapter 5. Erythrocytosis, Hemochromatosis, and Porphyrias
Chapter 6. White Blood Cell Disorders
Chapter 7. Bone Marrow Failure/Aplastic Anemia
Chapter 8. Platelet and Megakaryocyte Disorders
Chapter 9. Hemostasis
Chapter 10. Thrombosis
Chapter 11. Chronic Myeloid Leukemia
Chapter 12. Myeloproliferative Neoplasms
Chapter 13. Acute Leukemias and Hairy Cell Leukemia
Chapter 14. Myelodysplastic Syndromes
Chapter 15. Non-Hodgkin Lymphoma: Aggressive B-Cell Lymphoma
Chapter 16. Non-Hodgkin Lymphoma: Low Grade
Chapter 17. Chronic Lymphocytic Leukemia
Chapter 18. Multiple Myeloma and other Plasma Cell Neoplasms
Chapter 19. Immunodeficiency-Associated Lymphoproliferative Disorders
Chapter 20. T-cell and NK-Cell Neoplasms
Chapter 21. Hodgkin Lymphoma
Chapter 22. Other Neoplasms (Histiocytic and Dendritic Cell Neoplasms, Myeloid and Lymphoid Neoplasms with Eosinophilia
Chapter 23. Complications of Hematologic Malignancies/Hematologic Emergencies and Supportive Care
Chapter 24. Transfusion Medicine: Indications for using Blood Products and Risks Associated with Blood Products
Chapter 25. Introduction to Bone Marrow Transplantation
Chapter 26. Hematopoietic Cell Transplant in the Management of Hematologic Disease
Chapter 27. Cellular Therapy: Complications following Hematopoietic Cell Transplantation
Chapter 28. Cellular Therapy: CAR-T
Chapter 29.Biostatistics
Index
